The Lancet Haematology, April 2020, Volume 7, Issue 4, Pages e271-e352
Explore the current issue of The Lancet Haematology, a monthly journal dedicated to publishing content that advocates change in, or illuminates, haematological clinical practice
Explore the current issue of The Lancet Haematology, a monthly journal dedicated to publishing content that advocates change in, or illuminates, haematological clinical practice
TRANSFORM will recruit hundreds of thousands of men in an effort to identify the most effective screening strategies for prostate cancer. Talha Burki reports.
Launched as a public–private partnership funded by the Foundation for the National Institutes of Health, the Study to Advance Bone Mineral Density as a Regulatory…
All tested dosing regimens blocked some infections to a similar degree. Improved vaccine efficacy in participants infected during vaccination could suggest new strategies for highly…
Hydroxyurea dose escalation to MTD with dose optimisation significantly improved clinical responses and treatment outcomes, without increasing toxicities in children with sickle cell anaemia in…
Realizing Effectiveness Across Continents with Hydroxyurea (REACH) is a large prospective open-label, non-randomised trial of hydroxyurea (hydroxycarbamide) for children aged 1–10 years with sickle cell…
In patients with acute brain injury, a single ceftriaxone dose decreased the risk of early VAP. On the basis of our findings, we recommend that…
These findings underscore the possibility of differential efficacy of medical therapies according to disease distribution. These results warrant further exploration in forthcoming trials to better…
Adult-onset type 1 diabetes seems to have weaker familial aggregation and lower heritability than childhood-onset type 1 diabetes. This finding suggests a larger contribution of…
Vaccination is an effective strategy to mitigate the risk and disease burden of herpes zoster (shingles). With the arrival of a recombinant subunit vaccine (Shingrix),…
The herpes zoster subunit vaccine induces humoral and cellular immunity against herpes zoster with a good safety profile in patients with SLE. A larger study…